Flow Cytometry Market Projected to Hit $21.7 Billion by 2035

Flow cytometry market was valued at $10.2 billion in 2025 and is projected to reach $21.7 billion by 2035, growing at a CAGR of 7.9% during the forecast period (2026-2035).  The rapid expansion of diagnostic laboratories globally is emerging as a key growth driver for the global flow cytometry Market. As the number of laboratories increases, the overall testing capacity for clinical diagnostics has significantly expanded, particularly in areas such as cancer screening, hematology testing, immunodeficiency disorders, and infectious disease diagnostics. This growing diagnostic infrastructure is enabling higher volumes of routine blood and cell-based analyses, where flow cytometry plays a critical role due to its ability to deliver fast, accurate, and multi-parameter cellular characterization. In parallel, the evolution of diagnostic laboratories toward high-throughput and automated systems is further strengthening market demand. Modern laboratories are increasingly adopting automated sample processing platforms, high-parameter flow cytometers, and AI-assisted analytical software to improve efficiency and diagnostic precision. This technological shift is directly driving increased consumption of flow cytometry instruments, reagents, and consumables, which together form a significant portion of overall market revenue.

Browse the full report description of “Flow Cytometry Market Size, Share & Trends Analysis Report by Product Type (Instruments, Reagents & Consumables, Software), by Technology (Fluorescence-based Flow Cytometry, Mass Cytometry (CyTOF), and Spectral Flow Cytometry), by Application (Research Applications, Clinical Diagnostics, Drug Discovery & Development, and Others), Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/flow-cytometry-market

In emerging economies such as India, this trend is particularly pronounced, where the diagnostic landscape is rapidly expanding beyond metropolitan regions into Tier-2 and Tier-3 cities. India currently hosts approximately 34,729 diagnostic laboratories as of 2025, reflecting a strong and continuously growing healthcare testing ecosystem. Additionally, the presence of over 52,000 labs in Tier-1 cities and more than 41,000 labs in Tier-3 cities (FY 2023) highlights deepening penetration of diagnostic services across semi-urban and rural areas. This widespread expansion is being driven by increasing awareness of preventive healthcare, rising disease burden, and improved accessibility to diagnostic services. Organized players are also playing a crucial role in strengthening this network, with companies such as Dr. Lal PathLabs operating over 280–300 laboratories across India and steadily expanding into Tier-3 and Tier-4 regions. Collectively, these developments are accelerating the adoption of advanced diagnostic technologies like flow cytometry, thereby reinforcing its strong growth trajectory in the global market.

Technological Advancements and Workflow Automation in Flow Cytometry Market

The major companies operating in the global flow cytometry market include Cytek Biosciences, Becton, Dickinson and Company, Danaher, Sysmex, and Thermo Fisher Scientific, among others. Leading players are focusing on advancing spectral flow cytometry, automation, and high-throughput cellular analysis to improve research accuracy and efficiency.

• In May 2025, Cytek Biosciences launched the Cytek Aurora Evo flow cytometer, an upgraded full-spectrum system designed to improve throughput and automation in cellular analysis. The platform enhances spectral flow cytometry with faster sample processing, improved small particle detection, and standardized instrument performance. It aims to support more efficient and reproducible research in immunology, oncology, and related life sciences fields.

• In May 2023, Sysmex Corporation launched the XF-1600 Clinical Flow Cytometry System along with automated sample preparation tools (PS-10) and antibody reagents, expanding its clinical flow cytometry portfolio in Japan and other regions. The system is designed to automate the full flow cytometry workflow from sample preparation to analysis and reporting helping clinical laboratories improve efficiency and standardization in diagnostic testing, especially for blood-related cancers like leukemia and lymphoma.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Product Type
• Technology
• Application

• Competitive Landscape Cytek Biosciences, Inc., Becton, Dickinson and Company, Danaher Corp., Sysmex Corp, and Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Flow Cytometry Market Report Segment

By Product Type

• Instruments
• Cell Analyzers
• Cell Sorters
• Reagents & Consumables
• Software

By Technology

• Fluorescence-based Flow Cytometry
• Mass Cytometry (CyTOF)
• Spectral Flow Cytometry

By Application

• Research Applications
• Clinical Diagnostics
• Drug Discovery & Development
• Others

Global Flow Cytometry Market Report Segment

By Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/flow-cytometry-market